Colorectal Cancer Clinical Trial
Official title:
Testing Interventions to Motivate and Educate
This study is being done to see if teaching physicians and people who are at least 50 years old and have not been screened within guidelines for colorectal cancer about the importance of colorectal cancer screening will increase screenings for colorectal cancer. The researchers want to understand what ways will work best to motivate and educate both patients and the doctors and nurses who care for them.
Colorectal cancer (CRC) is the third leading type of cancer and the third leading cause of
cancer death in the United States. This study focuses on improving CRC screening in The Ohio
State University Primary Care Network (OSUPCN). Ohio has higher than average rates of CRC
mortality compared to the rest of the US. The study population for this study will also
include minority and older individuals as these groups have higher CRC incidence and
mortality rates.
The goal of this study is to test a program to improve CRC screening among male and female
patients over the age of 50 in 10 primary care clinics. This study will use physician
surveys, focus groups and a community advisory board to finalize the content of the
interventions. Five theoretical models form the theoretical framework of the study - the
health belief model, social networking, minority health communications model, PEN III, and
the transtheoretical model. The interventions will be directed at the clinic and patient
levels, and will be tested in a randomized design. Five clinics will receive the clinic plus
patient-directed interventions and 5 clinics will be randomized to usual care. The clinic
intervention will consist of provider, system and waiting room activities. The
individual-directed intervention will include three stepped stages for patients who have not
yet been screened: (1) a tailored physician letter, easy-to-read educational materials about
CRC and an FOBT information sheet and card; (2) follow-up telephone barriers counseling for
patients who do not complete CRC screening after receiving the letter; and (3) in person home
visits by lay health advisors (LHA) for those who do not complete CRC screening after
receiving the first two interventions. Research staff will conduct a process evaluation of
the interventions to identify problems in implementing them and determine the extent to which
each of the components is successfully carried out. They will also examine how components of
the intervention relate to the theoretical frameworks used to motivate CRC screening
completion. If successful, this program can easily be adapted for use by primary care
practices and clinics to improve CRC screening.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |